563 related articles for article (PubMed ID: 26136211)
1. CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli.
García-Gutiérrez E; Almendros C; Mojica FJ; Guzmán NM; García-Martínez J
PLoS One; 2015; 10(7):e0131935. PubMed ID: 26136211
[TBL] [Abstract][Full Text] [Related]
2. Clustered, regularly interspaced short palindromic repeat (CRISPR) diversity and virulence factor distribution in avian Escherichia coli.
Fu Q; Su Z; Cheng Y; Wang Z; Li S; Wang H; Sun J; Yan Y
Res Microbiol; 2017; 168(2):147-156. PubMed ID: 27789334
[TBL] [Abstract][Full Text] [Related]
3. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
[TBL] [Abstract][Full Text] [Related]
4. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems.
Almendros C; Guzmán NM; García-Martínez J; Mojica FJ
Nat Microbiol; 2016 Jun; 1(8):16081. PubMed ID: 27573106
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Escherichia coli CRISPR sequences in an undergraduate laboratory.
Militello KT; Lazatin JC
Biochem Mol Biol Educ; 2017 May; 45(3):262-269. PubMed ID: 27677251
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analyses of Shigella CRISPR structure and spacer classification.
Wang P; Zhang B; Duan G; Wang Y; Hong L; Wang L; Guo X; Xi Y; Yang H
World J Microbiol Biotechnol; 2016 Mar; 32(3):38. PubMed ID: 26867599
[TBL] [Abstract][Full Text] [Related]
7. Studying the features of 57 confirmed CRISPR loci in 29 strains of Escherichia coli.
Rahmatabadi SS; Nezafat N; Negahdaripour M; Hajighahramani N; Morowvat MH; Ghasemi Y
J Basic Microbiol; 2016 Jun; 56(6):645-53. PubMed ID: 26871258
[TBL] [Abstract][Full Text] [Related]
8. CRISPR adaptation in Escherichia coli subtypeI-E system.
Kiro R; Goren MG; Yosef I; Qimron U
Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex.
Semenova E; Savitskaya E; Musharova O; Strotskaya A; Vorontsova D; Datsenko KA; Logacheva MD; Severinov K
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7626-31. PubMed ID: 27325762
[TBL] [Abstract][Full Text] [Related]
10. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
[TBL] [Abstract][Full Text] [Related]
11. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of CRISPR shows separated natural groupings of Shigella subtypes and evidence of horizontal transfer of CRISPR.
Yang C; Li P; Su W; Li H; Liu H; Yang G; Xie J; Yi S; Wang J; Cui X; Wu Z; Wang L; Hao R; Jia L; Qiu S; Song H
RNA Biol; 2015; 12(10):1109-20. PubMed ID: 26327282
[TBL] [Abstract][Full Text] [Related]
14. Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
Aydin S; Personne Y; Newire E; Laverick R; Russell O; Roberts AP; Enne VI
J Antimicrob Chemother; 2017 Aug; 72(8):2213-2218. PubMed ID: 28535195
[TBL] [Abstract][Full Text] [Related]
15. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
[TBL] [Abstract][Full Text] [Related]
16. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
[TBL] [Abstract][Full Text] [Related]
17. [Identification and evaluation on methods with upstream flank sequences of CRISPR1, regarding
Liang WJ; Cui CC; Duan GC; Liu HY; Xu YK; Xi YL; Yang HY; Chen SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1607-1610. PubMed ID: 30572386
[No Abstract] [Full Text] [Related]
18. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
Cooper LA; Stringer AM; Wade JT
mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
[TBL] [Abstract][Full Text] [Related]
19. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
20. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
